Base
N3424612024-09-18New YorkClassification

The tariff classification of Sodium Sulfate-Potassium Sulfate-Magnesium Sulfate Oral Solution in dosage form, from India

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-30 · Updates monthly

Summary

The tariff classification of Sodium Sulfate-Potassium Sulfate-Magnesium Sulfate Oral Solution in dosage form, from India

Ruling Text

N342461 September 18, 2024 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9250 Trish O’ Mahoney NorthStar Healthcare Ltd. 3300 Cork Airport Business Park, Kinsale Road Cork T12 XN72 Ireland RE:  The tariff classification of Sodium Sulfate-Potassium Sulfate-Magnesium Sulfate Oral Solution in dosage form, from India Dear Ms. O’ Mahoney: In your letter dated September 4, 2024, you requested a tariff classification ruling. Sodium Sulfate-Potassium Sulfate-Magnesium Sulfate Oral Solution is a combination medication containing 17.5 grams of Sodium Sulfate, 3.13 grams of Potassium Sulfate and 1.6 grams of Magnesium Sulfate. It is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adult and pediatric patients 12 years of age and older. The applicable subheading for the Sodium Sulfate-Potassium Sulfate-Magnesium Sulfate Oral Solution in dosage form will be 3004.90.9250, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments…consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses…or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the digestive system: Laxatives.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations (CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and complete in every material respect. In the event that the facts are modified in any way, or if the goods do not conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2. Additionally, we note that the material facts described in the foregoing ruling may be subject to periodic verification by CBP. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division